Brian Slomovitz, MD, MS, FACOG
@GynCancerMD
Followers
3K
Following
838
Media
65
Statuses
838
Director, Gynecologic Oncology and CoChair, Cancer Research Committee, Mount Sinai Medical Center, Board of Directors and Uterine Cancer Lead, GOG Foundation
Miami Beach, FL
Joined April 2009
Honored to be a co-investigator on this practice changing trial. @GOG @MountSinaiMiami.
Study shows relacorilant + nab-paclitaxel improves PFS and OS in patients with platinum-resistant ovarian cancer. Dr Brian Slomovitz (@GynCancerMD) shares that the data; safety profile may suggest a new standard for patients with PROC 👇 #ASCO25.
0
1
12
Using precision molecular classifications to treat endometrial cancer! So many new options for our patients. @VPodder @MountSinaiMiami.
pubmed.ncbi.nlm.nih.gov
Precision oncology in endometrial cancer: closing the gap between potential and practice
0
1
5
Honored to work with such an esteemed group of global leaders. @angelica_onco @glaucobaiocchi @leitaomd @MountSinaiMiami
1
1
20
RT @IJGConline: #Editorial The challenge is no longer whether precision oncology can improve outcomes in #endometrialcancer but how rapidly….
0
6
0
So honored to take care of courageous women like Jackie. It is a privilege for me to have the opportunity to take care of my patients. @MountSinaiMiami.
facebook.com
Meet Jacqueline. With a tailored treatment plan for metastatic endometrial cancer—guided by Dr. Brian Slomovitz and advanced molecular testing—Jackie found renewed hope and strength. At the New...
0
0
2
Exciting breakthrough for our patients with ovarian cancer. @GOG @MountSinaiMiami @Corcept @IGCSociety
foxnews.com
Researchers discuss encouraging findings on a new drug tested in a phase 3 trial, which showed significant improvement in patients with treatment-resistant ovarian cancer.
0
1
6
So much fun seeing the presentations by the gyn onc fellows. Really great work. @GOG.
0
0
11
Congrats!!! Phenomenal work. You should be proud!!.
Its been an amazing journey, collaborating with some of the giants of contemporary GynOnc. @RparejaGineOnco.@ESGO_society, @IJGConline, @IGCSociety, @leitaomd, @pedroramirezMD, @reitanribeiro, @GynCancerMD .Over 400 surgeries, over 120 manuscripts published, Tons of good times.
0
0
4
Honored to discuss our practice changing study using tisotumab vedotin in patients recurrent cervical cancer. Led to full FDA approval. Really cool to discuss with my good friend, colleague, and leader of the cervical cancer portfolio @GOG @drleslie214 .@MountSinaiMiami.
🚨 New IGCS Journal Club Alert! 🚨.Dive into the latest in recurrent cervical cancer treatment with Dr. Brian Slomovitz, as he discusses Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer. This insightful session, moderated by Dr. Leslie Randall, is
0
2
11
Honored to participate in a recent @IJGConline conversations with one of my great mentors @pedroramirezMD.
#IJGCconversation @pedroramirezMD discusses GOG3053/ENGOT EN11/KEYNOTE B21:dMMR Outcomes with Brian Slomovitz @GynCancerMD #endometrialcancer #immunotherapy. 🎧 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society
1
1
17
RT @ASCO: New KEYNOTE-B21 #ClinicalTrial data in @JCO_ASCO was presented today at the #IGCS2024: pembrolizumab + chemotherapy may improve d….
ascopubs.org
Mismatch repair-deficient (dMMR) endometrial cancer (EC) is an inflamed phenotype with poor outcomes when meeting high-risk criteria and limited treatment options in the adjuvant setting. We report...
0
6
0
I am honored to be a part of this session with 2 colleagues from THE Ohio State. @omalleygynonc @GOG @MSMCObGyn @MountSinaiMiami @IGCSociety @IJGConline @IJGCfellows.
When considering potential benefit of chemo+rad in endometrial cancer, Arn's patients want to be aggressive, are 👍 w/ temp AEs if it improves survival. Watch this #ESMO24 follow-up w/ @GynCancerMD + @omalleygynonc for adjuvant therapy strategies. 👉
0
4
17
Looking forward to participating in this great CME event. I am honored to be on a lineup of speakers with these leaders.
Join us 9/28 for Oncology Congress & earn free CME/CE! Get updates on breast cancer, endometrial cancer, melanoma, bladder cancer & NSCLC. Speakers include @GynCancerMD, Dr. Rebecca Heist, @DrHBurstein,.@DanielPetrylak, @TheMillerLab & @sucharuprakash.
0
4
13
RT @ruralhealthcme: Join us 9/28 for Oncology Congress & earn free CME/CE! Get updates on breast cancer, endometrial cancer, melanoma, blad….
0
4
0
RT @MedscapeCME: WE'RE LIVE TOMORROW! 🚺 Endometrial cancer care is evolving! Is your clinical knowledge? Don't miss this review of the late….
0
2
0
RT @Annals_Oncology: 📢@ESMO24 concomitant paper: Important data from the ENGOT-en11/GOG-3053/KEYNOTE-B21trial - adjuvant pembrolizumab plu….
0
4
0
RT @GOG: To read the full publication, click link in bio or go to #clinicaltrials #GOGF #GOGPartners #GynecologicO….
0
3
0
RT @StephChuang: @GynCancerMD Amazing conversation between patient advocate Tiffany and @GynCancerMD on supporting all people. "I'm going….
0
3
0